Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum

L. Fialova, J. Svarcova, A. Bartos, I. Malbohan

. 2012 ; 57 (5) : 415-419.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14080845

Grantová podpora
NS10369 MZ0 CEP - Centrální evidence projektů

Antibodies have different avidities that can be evaluated using modified enzyme-linked immunosorbent assay (ELISA) techniques. We determined levels and avidities of antibodies to light (NFL) and medium (NFM) subunits of neurofilaments and tau protein in serum and cerebrospinal fluid (CSF) from 26 patients and anti-tau antibody levels and their avidities in 20 multiple sclerosis (MS) patients and 20 age- and sex-matched controls. Each sample was analyzed using both standard ELISA and also using a similar ELISA protocol with the addition of urea. The avidities of anti-neurocytoskeletal antibodies were higher in the CSF than those in serum (anti-NFL, p < 0.0001; anti-tau, p < 0.01; anti-NFM, n.s.). There was no relationship between avidities in serum and CSF for individual anti-neurocytoskeletal antibodies. We did not observe the relationship among the avidities of various anti-neurocytoskeletal antibodies. The avidities of anti-tau antibodies in the CSF were significantly higher in the MS patients than those in the controls (p < 0.0001). The study demonstrates the differences in avidities of CSF or serum neurocytoskeletal antibodies measured as the urea resistance by ELISA method. Avidity determination of anti-neurocytoskeletal antibodies could contribute to the evaluation of the immunological status of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14080845
003      
CZ-PrNML
005      
20141202154552.0
007      
ta
008      
141201s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-012-0105-x $2 doi
035    __
$a (PubMed)22566118
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Fialová, Lenka, $7 xx0074272 $u First Faculty of Medicine and General University Hospital, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University in Prague, Prague, Czech Republic $d 1957-
245    10
$a Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum / $c L. Fialova, J. Svarcova, A. Bartos, I. Malbohan
520    9_
$a Antibodies have different avidities that can be evaluated using modified enzyme-linked immunosorbent assay (ELISA) techniques. We determined levels and avidities of antibodies to light (NFL) and medium (NFM) subunits of neurofilaments and tau protein in serum and cerebrospinal fluid (CSF) from 26 patients and anti-tau antibody levels and their avidities in 20 multiple sclerosis (MS) patients and 20 age- and sex-matched controls. Each sample was analyzed using both standard ELISA and also using a similar ELISA protocol with the addition of urea. The avidities of anti-neurocytoskeletal antibodies were higher in the CSF than those in serum (anti-NFL, p < 0.0001; anti-tau, p < 0.01; anti-NFM, n.s.). There was no relationship between avidities in serum and CSF for individual anti-neurocytoskeletal antibodies. We did not observe the relationship among the avidities of various anti-neurocytoskeletal antibodies. The avidities of anti-tau antibodies in the CSF were significantly higher in the MS patients than those in the controls (p < 0.0001). The study demonstrates the differences in avidities of CSF or serum neurocytoskeletal antibodies measured as the urea resistance by ELISA method. Avidity determination of anti-neurocytoskeletal antibodies could contribute to the evaluation of the immunological status of patients.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a protilátky anti-idiotypické $x imunologie $x krev $x mok mozkomíšní $7 D000888
650    02
$a afinita protilátek $7 D000915
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a imunoglobulin G $x imunologie $x krev $x mok mozkomíšní $7 D007074
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a roztroušená skleróza $x imunologie $x krev $x mok mozkomíšní $7 D009103
650    12
$a neurofilamentové proteiny $x imunologie $7 D016900
650    12
$a proteiny tau $x imunologie $7 D016875
655    _2
$a srovnávací studie $7 D003160
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Švarcová, Jana. $7 xx0101454 $u First Faculty of Medicine and General University Hospital, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University in Prague, Prague, Czech Republic
700    1_
$a Bartoš, Aleš $7 xx0028753 $u Prague Psychiatric Center, Prague, Czech Republic; Third Faculty of Medicine, University Hospital Královské Vinohrady, Department of Neurology, Charles University in Prague, Prague, Czech Republic
700    1_
$a Matouš-Malbohan, Ivan, $d 1943- $7 xx0104988 $u First Faculty of Medicine and General University Hospital, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University in Prague, Prague, Czech Republic
773    0_
$t Folia Microbiologica $x 0015-5632 $g Roč. 57, č. 5 (2012), s. 415-419 $w MED00011005
910    __
$a ABA008 $b online $c 147 $y 4 $z 0
990    __
$a 20141201115601 $b ABA008
991    __
$a 20141202154545 $b ABA008
999    __
$a ok $b bmc $g 1049178 $s 879896
BAS    __
$a 3
BMC    __
$a 2012 $b 57 $c 5 $d 415-419 $i 0015-5632 $m Folia microbiologica $x MED00011005 $n Folia microbiol. (Prague)
GRA    __
$a NS10369 $p MZ0
LZP    __
$a 2014-12/abbo

Najít záznam

Citační ukazatele

Možnosti archivace